๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Reducing the costs of phase III cardiovascular clinical trials

โœ Scribed by Eric L. Eisenstein; Philip W. Lemons II; Barbara E. Tardiff; Kevin A. Schulman; M. King Jolly; Robert M. Califf


Book ID
116189701
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
108 KB
Volume
149
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


PLAY THE WINNER FOR PHASE II/III CLINICA
โœ Q. YAO; L. J. WEI ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 642 KB

In comparing two treatments under a typical sequential clinical trial setting, a 50-50 randomization design generates reliable data for making efficient inferences about the treatment difference for the benefit of patients in the general population. However, if the treatment difference is large and

Greenhouse-gas costs of clinical trials
โœ Anthony J McMichael; Hilary J Bambrick ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› The Lancet ๐ŸŒ English โš– 41 KB
Pharmacogenomics in cardiovascular clini
โœ R. Shah; B. Darne; D. Atar; E. Abadie; K.F. Adams; F. Zannad; on behalf of the p ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 61 KB